title: Changing incidence of nevirapine-induced cutaneous drug reactions: After revised guideline Nov 2011.
abstract: OBJECTIVE
  To study the change in the incidence and pattern of nevirapine (NVP)-induced adverse cutaneous reactions (ADR) after commencement of revised National AIDS Control Organisation (NACO) guidelines for initiation of antiretroviral therapy (ART) since Nov 2011.
  
  
  METHODS
  The study was conducted on patients who developed cutaneous reactions after starting NVP based regimen. According to the revised NACO ART initiation guidelines Nov 2011, ART should be started if CD4 count is < 350 cells/mm(3) in stages 1, and 2 and irrespective of CD4 count in stages 3, and 4. Patients were divided in groups A and B. Group A consisted of patients enrolled on NVP-based regimen during Jan 2011 to Oct 2011, whereas, in Group B patients from Nov 2011 to Aug 2012 were included. Grading of rash, appropriate investigations and management was done.
  
  
  METHODS
  In Group A, out of 645 patients 30 (4.66%) patients developed cutaneous reactions, where as in Group B out of 720, 65 (9.03%) patients presented with drug reaction. In Group A (n = 30) developed reaction as Grade 1 in 1.55% (n = 10), Grade 2 in 1.86% (n = 12), grades 3 and 4 in 0.76% (n = 5) and 0.47% (n = 3), respectively. In Group B (n = 65) developed reaction, out of which Grade 1 reaction was seen in 1.39% (n = 10), Grade 2 was seen in 2.78% (n = 20), grades 3 and 4 was seen in 3.33% (n = 24) and, 1.53% (n = 11), respectively.
  
  
  CONCLUSIONS
  There is a striking increase in the incidence of NVP-induced cutaneous reactions of all forms and considerable increase in frequency of severe kind of reactions with the revised guidelines.
authors: Department of Skin and VD, Head of ART Centre, B. J. Medical College, Ahmedabad, India.
authors: Archana J
authors: AJ
authors: Lokhande
authors: Amita
authors: A
authors: Sutaria
authors: Bela J
authors: BJ
authors: Shah
authors: Asha N
authors: AN
authors: Shah
keywords: Adverse drug reaction; Efavirenz; NVP- nevirapine; National AIDS control organisation; anti-tubercular treatment